HSPA5 and cancer: Specifically, BNE-RRC has been shown to inhibit cancer cell growth, exert anti-inflammatory effects, prevent drug resistance in cancer cells, and suppress the expression of glucose-regulated protein 78 (GRP78), a key protein involved in the unfolded protein response and associated with cancer progression and chemoresistance.